DR. REDDY S LABORATORIESPembelian
DRREDDY - Dr Reddy's Laboratories Ltd - Longterm - Bullish
1. Annual Revenue rose 16.78%, in the last year to Rs 25,725 Crores. Its sector's average revenue growth for the last fiscal year was 8.64%.
2. Annual Net Profit rose 106.52% in the last year to Rs 4,507 Crores. Its sector's average net profit growth for the last fiscal year was 2.34%.
3. Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
4. Interest Coverage Ratio is 51.85, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
5. Price to Earning Ratio is 19.19, lower than its sector PE ratio of 43.
2. Annual Net Profit rose 106.52% in the last year to Rs 4,507 Crores. Its sector's average net profit growth for the last fiscal year was 2.34%.
3. Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
4. Interest Coverage Ratio is 51.85, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
5. Price to Earning Ratio is 19.19, lower than its sector PE ratio of 43.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.